Free Trial

2,859 Shares in Itron, Inc. $ITRI Bought by PharVision Advisers LLC

Itron logo with Computer and Technology background

Key Points

  • PharVision Advisers LLC has invested $300,000 in Itron, Inc., acquiring 2,859 shares of the company in the first quarter of the year.
  • Institutional and hedge fund investors own approximately 96.19% of Itron's stock, indicating strong institutional interest in the company.
  • Several analysts have upgraded Itron's stock ratings recently, with Roth Capital and JPMorgan raising their price targets and ratings to "buy" and "overweight" respectively.
  • Five stocks to consider instead of Itron.

PharVision Advisers LLC purchased a new stake in Itron, Inc. (NASDAQ:ITRI - Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 2,859 shares of the scientific and technical instruments company's stock, valued at approximately $300,000.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Sowell Financial Services LLC acquired a new stake in shares of Itron in the first quarter valued at about $266,000. Envestnet Asset Management Inc. increased its stake in shares of Itron by 119.7% in the first quarter. Envestnet Asset Management Inc. now owns 77,060 shares of the scientific and technical instruments company's stock valued at $8,073,000 after buying an additional 41,984 shares during the period. Allspring Global Investments Holdings LLC grew its stake in Itron by 54.0% during the first quarter. Allspring Global Investments Holdings LLC now owns 6,278 shares of the scientific and technical instruments company's stock worth $658,000 after purchasing an additional 2,201 shares during the period. Principal Financial Group Inc. grew its stake in Itron by 2.5% during the first quarter. Principal Financial Group Inc. now owns 270,672 shares of the scientific and technical instruments company's stock worth $28,356,000 after purchasing an additional 6,700 shares during the period. Finally, Hsbc Holdings PLC grew its stake in Itron by 42.7% during the first quarter. Hsbc Holdings PLC now owns 31,610 shares of the scientific and technical instruments company's stock worth $3,277,000 after purchasing an additional 9,461 shares during the period. Institutional investors and hedge funds own 96.19% of the company's stock.

Insider Buying and Selling

In other news, SVP John F. Marcolini sold 565 shares of the firm's stock in a transaction that occurred on Monday, August 25th. The stock was sold at an average price of $125.31, for a total value of $70,800.15. Following the transaction, the senior vice president owned 14,396 shares in the company, valued at $1,803,962.76. This trade represents a 3.78% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Joan S. Hooper sold 970 shares of the firm's stock in a transaction that occurred on Monday, August 25th. The shares were sold at an average price of $125.31, for a total value of $121,550.70. Following the completion of the transaction, the chief financial officer owned 88,394 shares in the company, valued at $11,076,652.14. This represents a 1.09% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 3,037 shares of company stock valued at $380,566. 1.45% of the stock is currently owned by company insiders.

Itron Stock Up 2.2%

Itron stock traded up $2.61 during mid-day trading on Thursday, reaching $120.90. The stock had a trading volume of 203,984 shares, compared to its average volume of 593,396. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.75 and a current ratio of 2.04. Itron, Inc. has a fifty-two week low of $90.11 and a fifty-two week high of $140.04. The stock's 50-day simple moving average is $128.51 and its 200-day simple moving average is $117.09. The firm has a market capitalization of $5.53 billion, a PE ratio of 20.72, a price-to-earnings-growth ratio of 0.65 and a beta of 1.46.

Itron (NASDAQ:ITRI - Get Free Report) last announced its quarterly earnings data on Thursday, July 31st. The scientific and technical instruments company reported $1.62 EPS for the quarter, beating analysts' consensus estimates of $1.33 by $0.29. Itron had a return on equity of 19.69% and a net margin of 11.05%.The firm had revenue of $606.76 million during the quarter, compared to analysts' expectations of $610.36 million. During the same quarter last year, the firm posted $1.21 earnings per share. The company's revenue for the quarter was down .4% compared to the same quarter last year. Itron has set its FY 2025 guidance at 6.000-6.200 EPS. Q3 2025 guidance at 1.450-1.550 EPS. On average, sell-side analysts forecast that Itron, Inc. will post 5.33 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

ITRI has been the subject of several recent analyst reports. Wall Street Zen raised Itron from a "hold" rating to a "buy" rating in a research note on Saturday, August 2nd. Roth Capital raised their target price on Itron from $130.00 to $150.00 and gave the stock a "buy" rating in a research note on Tuesday, July 22nd. TD Cowen raised their target price on Itron from $139.00 to $145.00 and gave the stock a "buy" rating in a research note on Friday, June 20th. Stephens set a $130.00 target price on Itron in a research note on Monday, August 4th. Finally, Johnson Rice cut Itron from a "buy" rating to an "accumulate" rating in a research note on Friday, August 1st. Ten research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $136.55.

View Our Latest Stock Analysis on Itron

About Itron

(Free Report)

Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.

See Also

Institutional Ownership by Quarter for Itron (NASDAQ:ITRI)

Should You Invest $1,000 in Itron Right Now?

Before you consider Itron, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Itron wasn't on the list.

While Itron currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report
Like this article? Share it with a colleague.